Patterns of abnormal visual attention in myalgic encephalomyelitis.
Hutchinson, Claire V, Badham, Stephen P · Optometry and vision science : official publication of the American Academy of Optometry · 2013 · DOI
Quick Summary
This study tested whether people with ME/CFS have difficulty with visual attention—the ability to focus on and track things they see. Researchers compared 29 patients with ME/CFS to 29 healthy people using eye-tracking tests. The results showed that ME/CFS patients did struggle more with certain types of visual attention tasks, particularly when they had to focus on specific things or search for objects, supporting what many patients report experiencing.
Why It Matters
Many ME/CFS patients report cognitive and visual difficulties that are often dismissed or attributed to other causes. This study provides objective experimental evidence of visual attention impairment, validating patient experiences and suggesting a measurable biomarker that could eventually improve diagnosis and clinical recognition of ME/CFS.
Observed Findings
ME/CFS patients performed significantly worse than controls on selective attention (UFOV subtest), demonstrating difficulty filtering relevant from irrelevant visual information.
In spatial cueing tasks, ME/CFS patients were slower to detect targets, especially when directional cues were misleading or invalid.
ME/CFS patients were impaired on visual search tasks compared to controls.
Processing speed on the UFOV was comparable between patients and controls, suggesting speed alone did not explain the attention deficits.
Inferred Conclusions
Visual attention difficulties in ME/CFS are genuine, measurable impairments that extend beyond subjective patient reports.
Selective and divided attention are more affected than basic processing speed in this population.
Spinal cueing deficits suggest difficulty with attentional reorienting when expectations are violated.
These attention impairments could serve as an objective diagnostic marker for ME/CFS.
Remaining Questions
How do visual attention deficits correlate with disease severity, symptom burden, or post-exertional malaise in ME/CFS?
What This Study Does Not Prove
This study does not prove that visual attention problems are unique to ME/CFS or that they are caused by a specific biological mechanism. It only demonstrates that impairment exists in this patient group at a single point in time; it cannot establish whether these difficulties worsen with disease progression, improve with treatment, or correlate with symptom severity. The cross-sectional design means causation cannot be determined.
Are these attention impairments stable over time, or do they fluctuate with disease activity?
What underlying neurobiological mechanisms—such as thalamic dysfunction, brainstem involvement, or central sensitization—might explain these visual attention patterns?
Do visual attention impairments respond to treatments or rehabilitation strategies, and could improvements in attention predict clinical recovery?